Ebola Disease basics. Guidance on basics of disease, emergency services, screening, testing, infection control and Personal Protective Equipment for viral hemorrhagic fevers can be found in Center for Disease Control and Prevention (CDC) of the U.S. Government published on June 2, 2026.
Key points.
Types of Ebolaviruses There are specific regions for each Ebola virus that cause illness in people in that region.
Risk Factors Healthcare providers and caring family members without proper infection control have the highest risk of infection. However the Ebola virus has little risk to travelers or general public.
People can get Ebola by sharing body fluids of an infected sick or dead person. A person is only contagious when he begins showing symptoms of the disease. The disease does not pass through the air, or by being near someone or passing in public because infection does not spread through the air. Rarely, some people get the disease from contact with an infected animal like a bat or a non-human primate.
Prevention Avoid contact with body fluids of an infected dead person, including urine, sweat, vomit, breast milk, amniotic fluids, semen and vaginal fluid from people who are sick, or recovering from Ebola disease. Disinfect clothing, bedding, needles, medical equipment, or other items touched by the diseased person. Avoid contact with the body of someone who is suspected or confirmed to have Ebola disease. Or with the affected bats, forest antelopes, primates, or eat meat from these or unknown animals.
If you return from an area with an ongoing Ebola outbreak monitor your health for 21 days. Healthcare providers, order polymerase chain reaction to diagnose Ebola disease if they have been near patients. Seek medical care immediately, if you develop any symptoms of Ebola disease.
The US Food and Drug Administration has approved vaccine for prevention of the Ebola disease for adults 18 years old and those who are at potential risk of getting the disease.
Covid-19 is more deadly than Ebola. Dr. Mark Koretpeter, a physician and biodefense expert, said, the SARS-COV-2 virus that causes Covid-19 illness surpasses PN illness. The deaths from Covid -19, according to WHO, at more than 11,950 in Africa exceeded the total number of people who died during the largest-ever Ebola outbreaks. When someone becomes ill with Ebola virus becomes bedridden very quickly. The people who are at greatest risk for Ebola infection are those who have very close contact taking care of the sick, bedridden victim - whether they are in the home or the hospital. This makes the one who is infected with Ebola easy to isolate and quarantine much simpler than with Covid 19. When someone is infected with COVID he is contagious without knowing it and spread it to others through air during interactions with them.
The Time Article "Ebola Returns, How We can Fight Back." The Time Magazine has an extensive article titled 'Ebola Returns, How We can Fight back' by its senior editor Alice Park in July 27, 2026 issue.
Park traveled to Mongbwalu in the Democratic Republic of Congo where a woman had died and met with Dr. Marie Roseline Belizaire, the World Health Organization(WHO)'s emergency Director for Africa and locals who told her the story when she arrived to help the WHO's Ebola response. Mongbwalu, where the first cases of the Ebola outbreak occurred is a mining town in Ituri province attracts migrant workers. Some of the symptoms of Ebola - fever, headaches, and body aches, can be caused by exposure to the processes involved in the search for minerals. Malaria, and tuberculosis, which can also cause fever and bloody coughs and are prevalent in the area. "So Ebola was the last to come to the mind", Belizaire said. The region's natural resources also make it a target for political instability, corruption, and violent conflict, which all create a fertile ground for infectious diseases.
This Ebola outbreak likely started when an unsuspecting person encountered the virus, possibly by handling or eating the meat of wild animals. While Ebola has struck before, most notably in 2014, health authorities are concerned about the speed with which cases are mounting. With more than 1,400 cases and 400 deaths recorded by early July, this outbreak, which was declared in May, is now the second largest on record. The U.S. Centers for Disease Control and Prevention (CDC) has raised its response to the highest level, reflecting the escalating urgency of the situation. "We have never seen an epidemic increase as fast as this one," says Dr. Alan Gonzalez, deputy director of operations Doctors Without Borders. "This is massive."
It's impossible to stop viruses like Ebola from finding human hosts and causing disease. But it is possible to contain them quickly, and global health experts are alarmed by the world's worsening ability to do that. Our systems for responding to and confronting viruses are increasingly fractured and weakened, making everyone more vulnerable. In many important ways, the world is less prepared now than it was even a few years ago to address microbial threats. "The current epidemic in the D.R.C. is a stress test that, as of now, the world is failing," says Dr. Tom Frieden who led the CDC during the 2014 Ebola outbreak and who is now CEO of the nonprofit Resolve to Save Lives.
Park said about the U.S.'s role also looks markedly different than it did before President Donald Trump's second term. U. S. traditionally the largest supporter of global health security, both financially and through its scientific expertise, is no longer a member of WHO, which monitors pathogens and coordinates responses to emergency threats. The US withdrawal led to 3,000 job cuts and a retreat from some of the agency's activities such as disease surveillance and response. It is part of the U.S.'s shift toward an America First transactional approach to aid is already weakening global health security, as experts say.
More broadly, the Administration's plans to reframe foreign aid to focus more on bilateral agreements made directly with countries is centered on the principle that "foreign aid is not charity," says the senior department official. "It's a strategic tool for dealing directly with governments." While the agreements themselves are strictly related to health, the official said, the Administration takes strategic benefits and security alliances into account during negotiations. In June, Secretary of State Marco Rubio testified before Congress that when it comes to doling out foreign aid, including global health funds, "we are going to reward those that are good to the United States; we're not going to be as friendly to places that are not furthering our national interests."
"At both the macro and micro level, we are seeing changes that we haven't seen in 25 years," says Vincent Lin, associate director of health policy and advocacy at the global nonprofit Partners in Health. "It's a total reset of the system, and not something Congress agreed to or approved."
The U.S. is contributing to the Ebola response, but not in the ways that would have once been expected. In briefings, the CDC's incident manager for the Ebola response, Dr. Satish Pillai, said the CDC now has more than 400 personnel involved in the Ebola response, both in the U.S. and overseas, and has sent supplies like personal protective and lab testing equipment. The U.S. has also provided directly to combatting the outbreak, according to the State Department, including an additional $350 million for the outbreak and other humanitarian needs in Congo, Uganda, and South Sudan, and more to develop new treatments and vaccines. By comparison, in the 2014 outbreak, the U.S. provided nearly $2 billion more financial support, drawn from a package of $5.4 billion in emergency global health funding appropriated by Congress.
During his appearance before Congress, Rubio committed releasing $661 million more in matched funding from other donors to the Global Fund to Fight AIDS, TB and Malaria "very quickly" and said savings from closing USAID and address inefficiencies in foreign aid programs would be directed toward programs such as expanding access to a recently approved twice-a-year HIV-prevention medication.
Health leaders say the traditional financial support is not the only thing missing from this response. "The biggest deficit felt is a loss of partnership with one of our most reliable technical partners in the world - the U.S. CDC," said the executive director of the WHO Health Emergencies Program, who is deployed in Bunia, Congo. Recently, "we had a big partnerships meeting-we had the local and national public-health agency, the Africa CDC, but the missing partner in the room was the U.S. CDC."
American health care workers who travel to support the outbreak response may also be more at risk now than in the past. The Trump Administration announced a controversial plan to build an Ebola treatment and quarantine center in Kenya, which currently has no confirmed Ebola cases, on an air base to manage Americans who might have been exposed to the virus. Dr. Craig Spencer, who contracted Ebola in 2014 after volunteering in West Africa with Doctors Without Frontiers doubts whether such a makeshift facility will provide the same quality of care as established specialized centers in the U.S. The center was scheduled to open in late May but was blocked by a Kenyan high court after locals protested.
Being ready for Bundibugyo and other neglected viral strains requires investing in what if" scenarios. "There are a dozen or so viruses out there that we know can cause really serious illnesses in humans," Dr. Ashish Jha says. "We should be looking at all of the strains of all of those viruses and building vaccines and therapeutics against them now." The WHO is currently taking this approach by concentrating its efforts on a few major viral families that are most likely to erupt.
The U.S. donated doses of an experimental antibody treatment for Bundibugyo that the first patients in a trial received in early July. But this vaccine is needed to control the outbreak, and one that appears to work in animals already exists, says Teresa Lambe, head of vaccine immunology at Oxford University, who helped make and developed one of the first shots for COVID. "When we started this work, we started it at risk, relying on the fact that I had a very generous philanthropic donation." But those funds dried up; the barrier to creating the vaccine wasn't scientific, but financial.
Several weeks after the WHO sounded the alarm on Ebola, the money to continue those studies finally emerged from the philanthropic and intergovernmental group CEPI, which supports vaccine development against global health threats. At the end of May, CEPI announced an investment of nearly $62 million to develop three Bundibugyo vaccines, including the Oxford candidate.
Other Locations Involved in Confronting Ebola. Lambe is now working with the Serum Institute of India to finish testing the experimental vaccine in ferrets and hopes to have doses ready to test in people in Congo this summer. Moderna which partnered with CEPI to develop the first mRNA COVID vaccine also received CEPI funding to develop an mRNA vaccine-which has the advantage of speed, as shown during COVID at Bundibugyo. The final candidate, from IAVI, may take the longest to develop, around seven to nine months.
These time lags are measured in lives lost and more chances for the virus to find new hosts and spread-out of one country and into another, from one continent to another. In terms of money and lives, "building health systems is much cheaper than mounting an emergency response," says Sheila Davis, CEO at Partners in Health.
Meanwhile, while attending to the new outbreak, experts also are working to make sure new treatments and vaccines become available for whatever comes next. "We are working with a no-regrets policy," says Ihekweazu of the WHO.
He and other global health leaders agree on one thing: we have the tools and knowledge to confront and contain viruses like Ebola before they become epidemics or pandemics. But we lack the consolidated commitment to invest in the resources and workforce needed to use those tools and knowledge effectively. "We need to set up systems so the world isn't scrambling, as if it's never happened before, every time there is another emergency," says Frieden. "This is not rocket science. We know what to do. But it does take dedicated resources and money."
On August, 2026 CDC released Public Health Guidance for Ebola Disease. With the major references as follows:
On May 18, 2026, CDC began implementing enhanced travel screening, entry restrictions, and public health measures to prevent Ebola disease from entering the United States amid outbreaks in the Democratic Republic of Congo and Uganda.
Ebola spreads through communities and communities hold the knowledge required to stop it. They can identify illness early, alert health teams, help identify and trace contacts, challenge dangerous rumors and support families through access to treatment and safe, dignified burials. The response always moves faster when communities lead alongside national authorities and health workers.
One hundred days ago, the government of the DRC declared the country's 17th Ebola outbreak, following confirmation of the Bundibugyo virus. WHO subsequently declared a Public Health Emergency of International Concern, followed by Africa CDC's declaration of a Public Health Emergency of Continental security.
The scale of the emergency is immense. As of August 21, the DRC has reported 5,290 confirmed cases and 2,516 deaths across 56 health zones. This is now the second-largest Ebola outbreak ever recorded and it is moving faster than any previous one. It is being fueled by insecurity caused by decades of armed conflict that have undermined law, order and social services, and displaced more than a million people.
At the center of the response are the people who show up every day. Health workers care for patients. Laboratory teams identify the virus. Contact tracers follow its path. Community health workers build trust where fear and misinformation have taken hold. Burial teams help families honor their loved ones safely and with dignity.
They are working under extraordinary pressure, often in insecure and hard-to-reach areas. Some have contracted Ebola in the line of duty.
Their service must be met with action: safety, protective equipment, training, sufficient medical supplies, timely payment, psychosocial support and access to rapid diagnosis and high-quality supportive care if they fall ill. The safety of frontline workers is central to stopping transmission.
The response has made progress. Under the leadership of national authorities, Congolese responders, WHO, Africa CDC and partners have expanded surveillance, deployed laboratories, supported treatment centers, reinforced infection prevention and delivered essential supplies.
Neighboring Uganda has interrupted locally acquired transmission of the virus. Several health zones in northern Ituri and South Kivu provinces in the DRC have also interrupted transmission. These experiences prove that the outbreak can be stopped more quickly when rapid detection, decisive national leadership and close cooperation with communities break the chains of transmission.
But the continued emergency in the rest of Ituri province and five other provinces demands urgently scaled-up action.
To turn the corner, surveillance teams are being expanded and equipped to detect cases early and rapidly identify contacts. Safe clinical care and infection prevention measures are being increased wherever people seek treatment.
More risk communication and community engagement teams are being deployed to reach out to communities empower them to participate in the response and address barriers to care. More safe and dignified burial teams are working to prevent transmission associated with deaths. Special efforts are being made to reach vulnerable populations and communities in insecure and hard-to-reach areas.
But despite all these efforts, more is needed. We need to scale our response by two to three times current capacities, across all the response pillars.
Health facilities also require urgent protection from infection. As of August 20, 158 health workers have been infected and 45 have died. Every facility in an affected or high-risk area needs trained staff, protective equipment, clean water, sanitation and functioning infection-prevention systems.
National and local teams need predictable funding for surveillance, laboratories, treatment, logistics, infection prevention and community engagement. Frontline workers must be paid on time. Local organizations need direct support to work consistently with communities. Supplies must arrive before stocks run out.
But the continued emergency in the rest of Ituri province and five other provinces demands urgently scaled-up action.
To turn the corner, surveillance teams are being expanded and equipped to detect cases early and rapidly identify contacts. Safe clinical care and infection prevention measures are being increased wherever people seek treatment.
More risk communication and community engagement teams are being deployed to reach out to communities to empower them to participate in the response and address barriers to care. More safe and dignified burial teams are working to prevent transmission associated with deaths. Special efforts are being made to reach vulnerable populations and communities in insecure and hard-to-reach areas.
But despite all these efforts, more is needed. We need to scale our response by two to three times current capacities, across all the response pillars.
Health facilities also require urgent protection from infection. As of August 20, 158 health workers have been infected and 45 have died. Every facility in an affected or high-risk area needs trained staff, protective equipment, clean water, sanitation and functioning infection-prevention systems.
National and local teams need predictable funding for surveillance, laboratories, treatment, logistics, infection prevention and community engagement. Frontline workers must be paid on time. Local organizations need direct support to work consistently with communities. Supplies must arrive before stocks run out.
Delayed financing costs lives, and fragmented financing leaves gaps. Ebola exploits both. On the ground, we at WHO and Africa CDC have established tight integration among health and relief organizations working with the government. Donors therefore need to support and enhance that integration, rather than back siloed and disconnected efforts.
Cross-border coordination also must remain strong. People move within and between countries to trade, work, study, seek care and support their families. Borders must serve as bridges for coordinated public health action. This does not require closing borders or imposing blanket travel and trade restrictions. Such measures can disrupt response operations and livelihoods without stopping transmission. The priority is coordinated surveillance, rapid information-sharing and prepared health services along movement routes.
The first 100 days have made the priorities clear.
Find every case. Follow every contact. Break every chain of transmission, protect every health and frontline worker, save lives and ensure that no community is left behind. Bring testing and treatment closer to every affected community. Bolster cross-border coordination. Scale up international support. Turn every pledge into action.
WHO and Africa CDC will continue working with the DRC, neighboring countries, communities and partners to deliver on these priorities. Our responsibility is to bring the full strength of international and continental cooperation behind the nationally-led response.
Uganda and areas in DRC have shown how the course of the outbreak can be turned, through rapid detection, decisive action and close cooperation with communities. But these measures must be delivered at scale. Success depends on sustained national leadership, continental solidarity and international support. We must rise to this challenge, together.